Autopsy report · NCT03971357
Trial of Netarsudil for Acceleration of Corneal Endothelial Restoration
Cause of deathOther
“variance of outcome measures was substantially greater than anticipated in the statistical plan”
Life of this trial
- Registered 2 months before it started.
- Ran for about 2 years 1 month before it stopped.
- 19 participants enrolled.
- Results were posted on the registry 1 year 5 months after it ended.
Vital statistics
- Status
- Terminated
- Phase
- Phase 2, Phase 3
- Sponsor
- Price Vision Group
- Sponsor type
- Industry
- Conditions
- Fuchs' Endothelial Dystrophy
- Interventions
- Netarsudil; Placebo
- Participants
- 19
- Sites
- 1
- Countries
- United States
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.